South Asia Glucose Monitoring Devices Market size was valued at USD 330 million in 2021. It is expected to reach a value of USD 622.9 million by 2028, growing at a CAGR of 9.6% from 2022 to 2028. The market provides a detailed overview, which can be segmented by product and end-user. Glucometers have segmented the South Asia glucose monitoring devices market, Lancets, Testing Strips, and Other Glucose Monitoring Devices. The Glucometers segment is likely to be the largest and fastest-growing segment in terms of product type. Based on end-users, the South Asia glucose monitoring devices are segmented into Hospitals & Clinics, Homecare, and Others. According to precision business insights, the Homecare segment is predicted to register the fastest growth rate during the forecast period.
In August 2021, Abbott received the U.S. FDA approval for the Freestyle Libre 2 iOS application, which is compatible with iPhones. This provided a comprehensive digital offering for its FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) system.